# Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study

> **NCT03110861** · NA · COMPLETED · sponsor: **Taewoong Medical Co., Ltd.** · enrollment: 15 (actual)

## Conditions studied

- Congenital Heart Defect
- Pulmonary Valve; Insufficiency, Congenital
- Pulmonary Valve Stenosis

## Interventions

- **DEVICE:** Pulsta® Transcatheter Pulmonary Valve (TPV) Replacement

## Key facts

- **NCT ID:** NCT03110861
- **Lead sponsor:** Taewoong Medical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-22
- **Primary completion:** 2019-11-06
- **Final completion:** 2024-07-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110861, "Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03110861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*